Stroke after initiation of interferon-beta treatment for relapsing-remitting disseminated white matter disease. (Q48555670)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16674611%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Stroke after initiation of interferon-beta treatment for relapsing-remitting disseminated white matter disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16674611%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16674611%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Dohmen C

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16674611%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Impekoven P

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16674611%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Zaro-Weber O

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16674611%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Reske D

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16674611%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Rubbert A

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16674611%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jacobs AH

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16674611%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Petereit HF

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16674611%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16674611%20AND%20SRC:MED&resulttype=core&format=json

Acta Neurologica Scandinavica

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16674611%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16674611%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16674611%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

433-436

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16674611%20AND%20SRC:MED&resulttype=core&format=json

In vitro modulation of adhesion molecules, adhesion phenomena, and fluid phase endocytosis on human umbilical vein endothelial cells and brain-derived microvascular endothelium by IFN-beta 1a.

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00638.X

Biologic role of interferon beta in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00638.X

Lethal capillary leak syndrome after a single administration of interferon beta-1b

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00638.X

Thrombotic thrombocytopenic purpura developed suddenly during interferon treatment for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00638.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00638.X

Brain biopsy in primary angiitis of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00638.X

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00638.X

The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00638.X

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00638.X

Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C-associated cryoglobulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00638.X

Systemic lupus erythematosus induced by therapy with interferon-beta in a patient with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00638.X

Musculoskeletal and systemic reactions to biological therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00638.X

10.1111/J.1600-0404.2006.00638.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16674611%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference